#1
|
||||
|
||||
Ãèïåðëåéêîöèòîç è ýîçèíîôèëèÿ 63%
Óâàæàåìûå êîëëåãè!
Ñåãîäíÿ áðàëè àíàëèç êðîâè ó ðåáåíêà (05.06.2008 ã.ð.), íàçíà÷åíèå ñäåëàíî ïî ïîâîäó ÎÐÂÈ, ñî ñëîâ ìàìû "ñëåãêà ïîäêàøëèâàåò".  ÎÀÊ ïðè ëåéêîöèòîçå 68,8õ10 - ýîçèíîôèëû 63%. Ïîñòàâèëè â èçâåñòíîñòü ó÷àñòêîâîãî ïåäèàòðà, ðåáåíîê ãîñïèòàëèçèðîâàí â äåòñêóþ èíôåêöèþ. Òàêàÿ æå ñèòóàöèÿ áûëà â èþëå. Áûë âûñòàâëåí îïèñòîðõîç, îäíàêî ïî èññëåäîâàíèÿì ÈÔÀ è êàëà íå ïîäòâåðäèëñÿ. Ãåìàòîëîã â èþëå ñâîþ ïàòîëîãèþ èñêëþ÷èëà. Äåãåëüìåíòèçàöèÿ íå ïðîâîäèëàñü.Òðåõêðàòíûå èññëåäîâàíèÿ êàëà â èþëå - îòðèöàòåëüíûå (äåëàåì ïî Êàòî). Ñåãîäíÿ òîæå êàë íà ÿ\ã - îòðèöàòåëüíî. Íàø ðåãèîí ýíäåìè÷åí ïî îïèñòîðõîçó. Âñå ðåçóëüòàòû êàêèå óäàëîñü ñêîïèðîâàòü ïðèëàãàþ. Èíôåêöèîíèñò ãîâîðèò, ÷òî äàæå çà ÎÐÂÈ äàííûõ íåò, çàâòðà ïîâòîðíàÿ êîíñóëüòàöèÿ ãåìàòîëîãà. Ìåíÿ ñìóùàþò âûñîêèå öèôðû ëåéêîöèòîâ è ýîçèíîôèëîâ, íå î÷åíü õàðàêòåðíûå äëÿ áàíàëüíîé ãëèñòíîé èíâàçèè. Ñîáñòâåííî âîïðîñ, ÷òî ÿ, êàê çàâ. ÊÄË, ìîãó ïîðåêîìåíäîâàòü èç ëàáîðàòîðíûõ èññëåäîâàíèé ëå÷àùåìó âðà÷ó? Ñïàñèáî! |
#2
|
||||
|
||||
Âû ïðàâû: íå ïîõîæå íà ãåëüìèíòíóþ èíâàçèþ, îñîáåííî â ñâåòå ãèïåðýîçèíîôèëèè è íîðìàëüíîãî óðîâíÿ IgÅ...
áûëî áû èíòåðåñíî óñëûøàòü, êàê ãåìàòîëîã èñêëþ÷èëà ñâîþ ïàòîëîãèþ - ãèïåðýîçèíîôèëüíûé ñèíäðîì? åñòü ðåçóëüòàò ìèåëîãðàììû? öèòîãåíåòèêè? èììóíîôåíîòèïèðîâàíèÿ? ïîõîæèé ñëó÷àé êàøëÿ è ãèïåðýîçèíîôèëèè áåç ïîâûøåíèÿ IgÅ îïèñûâàëñÿ íåäàâíî: Thorax. 2010 Nov;65(11):1009, 1024. Persistent cough: an unusual cause. Idiopathic hypereosinophilic syndrome (HES).
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#3
|
||||
|
||||
Ñïàñèáî, Âàäèì Âàëåðüåâè÷!
Ïîãîâîðèëà ñ çàâ. äåòñêîé èíôåêöèåé: 1. ñåãîäíÿ ïîâòîðíàÿ êîíñóëüòàöèÿ ãåìàòîëîãà + ìèåëîãðàììà;âîçìîæíî èììóíîôåíîòèïèðîâàíèå; 2. äîäåëàåì âñå-ðàâíî òðåõêðàòíî êàë íà ÿ\ã; 3. ÈÔÀ íà òîêñîêàðîç; 4. ïîâòîðèì IgÅ. Âå÷åðîì âûëîæó ðåçóëüòàòû. |
#4
|
||||
|
||||
Ñåãîäíÿ â ÎÀÊ ëåéêîöèòîâ 82 òûñ., ýîçèíîôèëû 75%.
Ó ðåáåíêà ïðè òåìïåðàòóðå âûøå 38 ïîÿâëÿþòñÿ êîëüöåâèäíûå ìàëèíîâî-ðîçîâûå âûñûïàíèÿ íà ñòîïàõ è ãîëåíè, êîòîðûå ïðîõîäÿò â òå÷åíèå ñóòîê ïîñëå ñíèæåíèÿ òåìïåðàòóðû (ìàìà ïîêàçàëà ôîòîãðàôèè), ñî ñëîâ ìàìû âûñûïàíèÿ ðåáåíêà íå áåñïîêîÿò. Æäåì ãåìàòîëîãà. Ñåãîäíÿ ïîñòóïèëà åùå îäíà äåâî÷êà 6 ëåò, ëåéêîöèòû 22 òûñ., ýîçèíîôèëû 46%... |
#5
|
||||
|
||||
Çàâòðà ðåáåíêà ïåðåâîäÿò â äåòñêóþ ãåìàòîëîãèþ: ïëîòíûå øåéíûå ëèìôîóçëû, ãåïàòîñïëåíîìåãàëèÿ. Ïóíêòèðîâàòü è äåëàòü èììóíîôåíîòèïèðîâàíèå áóäóò òîæå òàì.
Ds:ÎÐÇ. Ëåéêåìîèäíàÿ ðåàêöèÿ íåÿñíîãî ãåíåçà. |
#6
|
||||
|
||||
Êàê çàâåäóþùåé ëàáîðàòîðèè, ñîâåòóþ Âàì ðàçîáðàòüñÿ ñ ãåìàíàëèçàòîðîì, ÌÑÍÑ=43,4!!! È åùå åñòü íåêîòîðûå íåñîîòâåòñòâèÿ â àíàëèçå íà àïïàðàòå îò 21.07.11.
Åñëè ó Âàñ 3-diff, (êñòàòè, à ãäå ãðàíóëîöèòû?) òî ýîçèíîôèëû äîëæíû ïîïàäàòü â çîíó ñðåäíèõ êëåòîê (íå ñîâñåì ïðàâèëüíî èõ èìåíóþò ìîíîöèòàìè), à ó âàñ èõ âñåãî 4%. Îòñþäà âûòåêàåò åùå äâà âîïðîñà - êàê âûñòàâëåíû äèñêðèìèíàòîðû íà àïïàðàòå, è âñå ëè â ïîðÿäêå ñ îêðàñêîé ìàçêîâ êðîâè. |
#7
|
||||
|
||||
Assandra, ñïàñèáî. ß â ýòîé ëàáîðàòîðèè ðàáîòàþ ñ ñåíòÿáðÿ, àíàëèçàòîðû ïðèâåëè â ïîðÿäîê. Íî ýòî, äåéñòâèòåëüíî, ýîçèíîôèëû, ïîòîìó ÷òî ñ îêðàñêîé ìàçêîâ ó íàñ âñå õîðîøî. Çàâòðà âûëîæó êàðòèíó êðîâè.
|
#8
|
||||
|
||||
Öèòàòà:
ïðàâèëüíåå äèàãíîç çâó÷àë áû: èäèîïàòè÷åñêèé ãèïåðýîçèíîôèëüíûé ñèíäðîì
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#9
|
||||
|
||||
Ñ ó÷åòîì ãåïàòîñïëåíîìåãàëèè è ëèìôîóçëîâ, åñëè äåéñòâèòåëüíî ÒÀÊÎÉ ãèïåðëåéêîöèòîç è ýîçèíîôèëèÿ - ñòîèò â ìàçêå ïîèñêàòü áëàñòû, âîçìîæíî òóò "ïðåëþäèÿ" ÎËË.
Ñ äðóãîé ñòîðîíû - ñìóùàåò òàêîå êîëåáàíèå ïîêàçàòåëåé êðîâè îò ðåçêî ïàòîëîãè÷åñêèõ äî íîðìàëüíûõ â òå÷åíèå íåñêîëüêèõ äíåé. Î÷åíü ìàëî èíôîðìàöèè î ïàöèåíòå - ýòî áåäà äëÿ âñåõ ëàáîðàíòîâ. "Íàéäè òî, íå çíàþ ÷òî". |
#10
|
||||
|
||||
Öèòàòà:
Lab Hematol. 2008;14(1):7-9. Acute lymphoblastic leukemia with hypereosinophilia and 9p21 deletion: case report and review of the literature. D'Angelo G, Hotz AM, Todeschin P. Laboratorio di Chimica-Clinica, Ematologia e Microbiologia, Ematologia/Coagulazione, Azienda Ospedaliera S. Antonio Abate-Gallarate, Varese, Italy. Acute lymphoblastic leukemia (ALL) associated with eosinophilia is very rare, with approximately 44 reported cases. We are reporting this case not only because of the rarity of ALL with peripheral blood eosinophilia, but also because we observed a homozygous deletion of the 9p21 locus corresponding to the p16 gene, a cytogenetic abnormality that was not reported in other documented cases. ALL with eosinophilia must be considered a distinct clini-copathologic entity. It is very important for clinicians to be aware of this specific manifestation of ALL within the context of a persistent peripheral eosinophilia, particularly if no lymphoblasts are present in the peripheral blood.
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#11
|
||||
|
||||
Áûòü ìîæåò ïðèãîäèòüñÿ íà áóäóùåå:
ïîâûøåíèå êîíöåíòðàöèè êîáàëàìèíà â êðîâè ìîæåò ïîìî÷ü â íà÷àëüíîé äèôôåðåíöèðîâêå ãèïåðýîçèíîôèëüíîãî ñèíäðîìà îò âòîðè÷íîé ýîçèíîôèëèè: Clin Biochem. 2003 Nov;36(8):585-90. Significance of elevated cobalamin (vitamin B12) levels in blood. Ermens AA, Vlasveld LT, Lindemans J. Clinical Laboratory, Amphia Hospital, lokatie Langendijk, Breda, Netherlands. Elevated levels of serum cobalamin may be a sign of a serious, even life-threatening, disease. Hematologic disorders like chronic myelogeneous leukemia, promyelocytic leukemia, polycythemia vera and also the hypereosinophilic syndrome can result in elevated levels of cobalamin. Not surprisingly, a rise of the cobalamin concentration in serum is one of the diagnostic criteria for the latter two diseases. The increase in circulating cobalamin levels is predominantly caused by enhanced production of haptocorrin... --- Cobalamin (vitamin B12) and B12 binding proteins in hypereosinophilic syndromes and secondary eosinophilia. Zittoun J, Farcet JP, Marquet J, Sultan C, Zittoun R. Blood. 1984 Apr;63(4):779-83. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#12
|
||||
|
||||
Âàäèì Âàëåðüåâè÷, ñïàñèáî! ß óæå îò Âàñ ñòîëüêî ïîëåçíîé èíôîðìàöèè ïîëó÷èëà, ÷òî ïðîñòî íå õâàòàåò ñëîâ, ÷òîáû âûðàçèòü áëàãîäàðíîñòü! Îòäåëüíîå ñïàñèáî, çà ñâåäåíèÿ ïî ÆÄÀ!
|
#13
|
||||
|
||||
Assandra, ñ Âàìè ñ óäîâîëüñòâèåì áû ïîîáùàëàñü ëè÷íî!
Êîëåáàíèå ïîêàçàòåëåé êðîâè áûëè ñâÿçàíû ñ òåì, ÿ ñàìà òîëüêî â÷åðà óçíàëà, ðåáåíîê ïîëó÷àë "ïðåäíèçîëîí â èíôóçèÿõ -5äíåé, ÈÒ â òå÷åíèè 8äíåé ñ öåëüþ äåçèíòîêñèêàöèè è ãèïîñåíñèáèëèçàöèè..." |